Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

NCT04609904 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2187

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: BGF MDI 320/28.8/9.6 μg
DRUG: BGF MDI 320/14.4/9.6 μg
DRUG: BFF MDI 320/9.6 μg
DRUG: BFF pMDI 320/9 μg

Sponsor

AstraZeneca